These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 34447468)
1. Emodin inhibits the proliferation of papillary thyroid carcinoma by activating AMPK. Li W; Wang D; Li M; Li B Exp Ther Med; 2021 Oct; 22(4):1075. PubMed ID: 34447468 [TBL] [Abstract][Full Text] [Related]
2. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition. Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619 [TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxy vitamin D3 inhibits the Ras-MEK-ERK pathway and regulates proliferation and apoptosis of papillary thyroid carcinoma. Li B; Lv L; Li W Steroids; 2020 Jul; 159():108585. PubMed ID: 31982425 [TBL] [Abstract][Full Text] [Related]
4. SQSTM1/p62 Promotes Cell Growth and Triggers Autophagy in Papillary Thyroid Cancer by Regulating the AKT/AMPK/mTOR Signaling Pathway. Yu F; Ma R; Liu C; Zhang L; Feng K; Wang M; Yin D Front Oncol; 2021; 11():638701. PubMed ID: 33937040 [TBL] [Abstract][Full Text] [Related]
5. Emodin treatment of papillary thyroid cancer cell lines Liu X; Wei W; Wu YZ; Wang Y; Zhang WW; Wang YP; Dong XP; Shi Q Oncol Lett; 2023 Dec; 26(6):514. PubMed ID: 37927413 [TBL] [Abstract][Full Text] [Related]
6. Lentivirus-mediated shRNA interference of trefoil factor 3 blocks cell viability, migration and invasion in the papillary thyroid carcinoma cells. Wu J; Zhang H; Zhang W; Zhang J; Lin X; Xue G; Gao F Neoplasma; 2018; 65(2):169-177. PubMed ID: 29534576 [TBL] [Abstract][Full Text] [Related]
7. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma. Sun Y; Zhang L; Zhang S Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394 [TBL] [Abstract][Full Text] [Related]
8. Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer. Tang Q; Wu J; Zheng F; Hann SS; Chen Y Cell Physiol Biochem; 2017; 41(1):339-357. PubMed ID: 28214826 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-150-5p affects cell proliferation, apoptosis, and EMT by regulation of the BRAF Yan R; Yang T; Zhai H; Zhou Z; Gao L; Li Y J Cell Biochem; 2018 Nov; 119(11):8763-8772. PubMed ID: 30126001 [TBL] [Abstract][Full Text] [Related]
10. STAT1-induced upregulation of lncRNA LINP1 promotes cell proliferation and inhibits apoptosis via AMPK signaling pathway in papillary thyroid cancer. Li HP; Yang TZ; Wei L; Ge YF; Meng QS Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8911-8917. PubMed ID: 32964981 [TBL] [Abstract][Full Text] [Related]
11. [Effect of Nifuroxazide on Proliferation, Migration, and Invasion of Thyroid Papillary Carcinoma Cells]. Hu Y; Liang LB; Zhang Q; Lan F; Lin K; He H; Li SQ Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jan; 50(1):48-54. PubMed ID: 31037904 [TBL] [Abstract][Full Text] [Related]
12. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma. Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818 [TBL] [Abstract][Full Text] [Related]
13. Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway. Deng G; Ju X; Meng Q; Yu ZJ; Ma LB Mol Med Rep; 2015 Sep; 12(3):4427-4433. PubMed ID: 26081222 [TBL] [Abstract][Full Text] [Related]
14. LncRNA BISPR promotes the progression of thyroid papillary carcinoma by regulating miR-21-5p. Zhang H; Cai Y; Zheng L; Zhang Z; Lin X; Jiang N Int J Immunopathol Pharmacol; 2018; 32():2058738418772652. PubMed ID: 29856242 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis. Lee KH; Lee MS; Cha EY; Sul JY; Lee JS; Kim JS; Park JB; Kim JY Mol Med Rep; 2017 Apr; 15(4):2163-2173. PubMed ID: 28260110 [TBL] [Abstract][Full Text] [Related]
16. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma. Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328 [TBL] [Abstract][Full Text] [Related]
17. Nrf2-mediated neuroprotection against oxygen-glucose deprivation/reperfusion injury by emodin via AMPK-dependent inhibition of GSK-3β. Park SY; Choi YW; Park G J Pharm Pharmacol; 2018 Apr; 70(4):525-535. PubMed ID: 29424025 [TBL] [Abstract][Full Text] [Related]
18. The mTOR Kinase Inhibitor CZ415 Inhibits Human Papillary Thyroid Carcinoma Cell Growth. Li X; Li Z; Song Y; Liu W; Liu Z Cell Physiol Biochem; 2018; 46(2):579-590. PubMed ID: 29617677 [TBL] [Abstract][Full Text] [Related]
19. A novel dual AMPK activator/mTOR inhibitor inhibits thyroid cancer cell growth. Plews RL; Mohd Yusof A; Wang C; Saji M; Zhang X; Chen CS; Ringel MD; Phay JE J Clin Endocrinol Metab; 2015 May; 100(5):E748-56. PubMed ID: 25710562 [TBL] [Abstract][Full Text] [Related]
20. LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway. Sun W; Qian K; Guo K; Chen L; Xiang J; Li D; Wu Y; Ji Q; Sun T; Wang Z Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):382-389. PubMed ID: 32227107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]